Relay Therapeutics Insider Sells 21,000 Shares for $166,700 After 65% Run

Relay Therapeutics is a clinical-stage biotechnology company leveraging computational modeling and structure-based drug design to develop precision small molecule therapies. The company differentiates itself through proprietary technology platforms and strategic collaborations, aiming to address unmet needs in oncology and genetic diseases. With a pipeline of innovative candidates and partnerships with industry leaders, Relay Therapeutics is positioned to advance next-generation targeted therapies.Operates ...